A Case of Cryptococcal Meningitis
in Hiv positive patient in A tertiary care hospital in Kancheepurum
district, Tamilnadu, India
Shanthi B1, Kannan I2
1Dr Shanthi Banukumar, Professor, Department of Microbiology, Tagore
Medical College and Hospital, Rathinamangalam, Chennai, India, 2Dr I
Kannan, Associate professor, Department of Microbiology, Tagore Medical
College and Hospital, Rathinamangalam, Chennai, India
Address for Correspndence: Dr. Shanthi Banukumar, Professor of
Microbiology, Tagore Medical College and Hospital, Rathinamangalam,
Chennai, Email: shanthibanukumar@gmail.com
Abstract
Cryptococcal meningitis has been reported in recent years as major life
threatening opportunistic infection associated with HIV with a leading
cause of mortality ranging from 7 – 15 % around the world
& 6% in United States of America. Approximately 25 –
30 % overall mortality rate is encountered in patients suffering from
Cyrptococcal meningitis. Among the survivors 40% have significant
neurological disorders like loss of vision, decreased mental function,
hydrocephalus, cranial nerve palsies with relapse occurring in 25% of
cases. It frequently presents as subacute meningitis and is a sporadic
infection that affects both immunosuppressed patients (50%) and
nonimmunosuppressed patients. This is the first case of cryptococcal
meningitis reported in our Hospital in a HIV positive patient reported
in our area – Rathinamangalam – Kancheepuram
district – during a span of 2 years case study 2013 to 2014.
Key words:
Meningitis, Cryptococcus neoformans, Human immune deficiency virus
Manuscript received: 25th
Jan 2015, Reviewed:
14th Feb 2015
Author Corrected:
4th Mar 2015, Accepted
for Publication: 11th Mar 2015
Introduction
Cryptococcal meningitis has been reported in recent years as major life
threatening opportunistic infection associated with HIV with a leading
cause of mortality ranging from 7 – 15 % around the world and
6% in United States of America [1]. Among the survivors 40% have
significant neurological disorders like loss of vision, decreased
mental function, hydrocephalus, cranial nerve palsies with relapse
occurring in 25% of cases [2].
Cryptococcus is yeast like fungus, round to oval in shape with a large
polysaccharide capsule ranging from 1 to 30 micron when cultivated in
lab [3] and in natural environment it is smaller and poorly
encapsulated. There are four capsular types A, B, C and D. Weathered
pigeon droppings commonly contain serotypes A or D (Cryptococcus
neoformans). It has been isolated from litter around the trees of the
species Eucalyptus camaldulesis and E. tereticornis isolates have been
so far typed as serotype B. It is the only pathogenic species of human.
Var gatti (serotype B and C) has a limited geographic distribution and
affects immunocompetent male host in their second decade on life
predominantly.
Human infection s is contracted through inhalation [4]. Cryptococcus
neoformans is isolated from the nasopharynx of 50% of the AIDS patients
with cryptococcosis and not isolated from AIDS patients without
cryptococcosis, supporting inhalation as the mode of entry. Crytococcal
meningitis is the AIDs defining illness in 88% of patients. The median
survival without antifungal therapy is 14 days, range (0- 233days). CNS
invasion is secondary to haematogenous infection or may represent
reactivation of the disease. The time of onset of symptoms for
diagnosis ranges from days to months [5].Infection usually presents as
a sub acute process. We report a case of cryptococcal meningitis since
60 % of patients with cryptococcosis present as cryptococcal meningitis
and is higher in AIDS patients causing 6,00,000 deaths annually
particularly in resource limited countries [6].The predisposing factors
are AIDS with CD4 cell count less than 200 cells / microliter,
Hodgkin’s disease, diabetes and in patients receiving
corticosteroids or immunosuppressants. It is usually reported in
patients with advanced stage of immunosuppressant with a median CD4
cell count below 50 cells / microliter [7]. Incubation period is 14- 25
days. It can cause pulmonary, cutaneous, osseous and visceral
cryptococcosis. Diagnosis is made by identifying the organism or its
antigen in C.S.F, urine and in blood.
Case
Report
A 35 year old farmer by profession was admitted to our medical
outpatient department with a complaint of weakness of all the four
limbs, gradual in onset and progressive for the past one month
associated with low grade fever also for one month. He had neck pain
for past 1 month, visual disturbances on and off, difficulty in
bringing the food to mouth - 5 days. On examination, the patient is
disoriented, partially responded to commands. He had signs and symptoms
of meningitis, convergent squint and bilateral rectal muscle palsy.
Muscle power was 3/5 in all the four limbs. Facial nerve was normal.
Sensations were intact and bladder & bowel function were normal.
Routine blood investigations viz., blood sugar, TC, DC, smear study,
serum electrolytes, urea, creatinine reports were done and found to be
normal. ESR alone was raised. CT plain scan was normal and x-ray chest
NAD. Lumbar puncture fluid was sent to central laboratory with a note
that fluid was under increased pressure and with a provisional
diagnosis of Tuberculous meningitis. Biochemical analysis of the fluid
showed increased protein of 130/ dL and decreased sugar to 18 mg /dL.
Microbiological & pathological investigations were performed.
As a routine, the wet mount preparation carried out which showed the
presence of round to oval cells some in budding stage. Gram stain
preparation also revealed the same as round to oval yeast like cells
some in budding stage on an average 1-2 cells / oil immersion field
(Figure 1). The India ink preparation was done. A small drop of
centrifuged deposit of CSF placed on a glass slide with a drop of India
ink with the cover slip on and was observed under 10x and 100x. Thick
walled spherical to oval yeast like cells with a clear halo around was
seen and few among them showed budding stage (Figure 2). Provisional
diagnosis of crytococcal meningitis was made. The diagnostic yield of
C. neoformance in C.S.F. by India Ink preparation is 87- 89%, by C.S.F.
fungal culture is 87- 95 % & by blood culture is 75- 100%. [8]
Fig1:
Gram’s staining of CSF showing budding yeast
cells
Fig 2: India ink preparation of CSF showing capsulated
oval yeast like budding cells
Fig 3: CSF
fungal culture showing the growth of Cryptococcus neoformans
Patient serum was subjected to HIV testing initially done by rapid test
and confirmed positive by routine ELISA HIV antigen detection. CSF
deposit was cultured on SDA incubated at 25OC for 72 hrs. After 48 hrs
it showed smooth white flat, irregular colonies which turned mucoid on
third day (Figure 3). They were identified as Cryptococcus neoformans
based on gram’s stain, cryptococcal capsular polysaccharide
stain, urease production, nitrogen assimilation, sugar fermentation and
mice pathogenicity test as per standard methods. CSF deposit also sent
for antigen detection by latex agglutination test (LAT) which confirmed
the diagnosis. LAT for detection of cryptococcal capsular
polysaccharide antigen is a reliable and rapid method for diagnosis of
Cryptococcal neoformans.
Other investigations like sputum culture for bacterial organisms,
Gram’s stain smear of sputum, smear for AFB, urine wet mount,
motion examination were carried out to rule out other opportunistic
infection since the patient is HIV positive . There was no evidence of
other opportunistic infection. Adrenal gland CT scan was done to
evaluate the size and consistency of it to rule out adrenal
insufficiency which occurs secondary to cryptococcal invasion [8]. CT
scan revealed a normal study. Patient was started on antifugal drug
amphotericin B 1 gm I.V. bd and fluocytosine 1 gm I.V. bd. Due to HIV
positivity the patient was transferred to Government Tuberculosis and
Thoracic Medicine, Tambaram, Sanatorium, Chennai, Tamil Nadu, India
where he expired on the third day inspite of adequate treatment.
Discussion
Prevalence of cryptococcosis varies from place to place. According to
Kisenge et al. [9] and Kumar et al. [10] India ink preparation is
positive in 60% and 70 – 90 % of AIDS patient respectively.
Crytococcus infection is more common in male than female probably due
to the difference in exposure rather than the host susceptibility [11].
India ink preparation and culture methods are complementary to each
other though differences were observed in many studies and both were
therefore recommended for an effective diagnosis of cryptococcosis. The
cellular reactions and chemical changes in CSF usually resemble those
seen in tuberculous meningitis and hence diagnosis is based on the
isolation of organism from the clinical specimen and demonstration of
the same after culture. The frequent clinical presentation of
cryptococcosis is meningitis. Cryptococcal meningitis ranked second in
frequency among the infectious agents causing neurological disease in
AIDS patients. It is detected in 50% of cases with India ink
preparation in cerebrospinal deposit. Detection of cryptococcal antigen
in spinal fluid has 90% sensitivity and also is very specific.
Out of 5442 patients who has been screened for HIV in our institution
during a span of 2 years (2013 – 2014), 22 patients were
positive for HIV which turned out to be 0.40% in our area .This
percentage of HIV positivity more or less coincides with the study
conducted in India, for a period of 3yrs 2009 – 2012 (0.31%
in adults). All positive patients were screened for various
opportunistic infections and this is the first Crptococcal meningitis
case that is reported in and around Kancheepuram district.
Conclusion
From our study it is inferred that cryptococcosis is rife in AIDS
patients. As the symptoms are not pathognomonic and to minimize the
death toll in AIDS affected patients, routine checkup should be
integrated with management of AIDS. We recommend that laboratory
diagnosis of cryptococcal infection should be performed in all HIV
patients and anti retrovirus treatment to be intensified so that the
risk of cryptococcosis is reduced in such cases.
Funding:
Nil, Conflict of
interest: None initiated.
Permission from IRB:
Yes
References
1. Speed B, Dunt D. Clinical & host differences between
infections with the two varieties of Cryptococcus neoformans. Clin
Infect Dis.1995; 21(1):28 – 36. [PubMed]
2. Jain N, Wicks BL , Keller Sm, Fu J, Kesadevall A, Jain P
et al .Molecular epidemiology of Cryptococcus neoformans strains in
India. J Clin Microbiol. 2005: 43(11): 5733- 5742. [PubMed]
3. Aberg JA, Powderly WG. Cryptococcosis. Adv Pharmacol
1997; 37: 215-51. [PubMed]
4. Sukroongreung S, Eampokalap B, Tansuphaswadikul S,
Nilakul C, Tantimavanich.S. Recovery of Cryptococcus
neoformans patients. Mycopathologia 1998;143(3) :131-134. [PubMed]
5. Mitchell TG, Perfect JR. Cryptococcosis in the era of
AIDS – 100yrs after the discovery of Cryptococcus neoformans.
Clin Microbiol Rev 1995; 8(4): 515-48. [PubMed]
6. Park B.J,Wannemuehler.K.A,Marstan B.J, Govender N, Pappas
P.G, Chiller T.M, Estimation of the current global burden of
cryptococcal meningitis among persons living with HIV /AIDS. AIDS.
2009; 23(4): 525- 530. [PubMed]
7. Van der Horst CM, Saag MS, Cloud GA, Hammil RJ,
Grabill.R. Sobel JD.Treatment of Cryptococcal meningitis associated
with AIDS. N Engl J Med 1997; 337(1): 15-21. [PubMed]
8. Abhilash KPP, Mitra S, Arul JJJ, Raj PM, Balajii V,
Kannangai R, Thomas SA, Abraham OC. Changing paradigm of Cryptococcus
meningitis: An eight year experience from a tertiary hospital in South
India. Ind J Med Micro, 2015;33 (1) 25 – 29. [PubMed]
9. Perfect JR. Crptococcosis. Infect. Dis .Clin. North Am
.1989 (1); 3:77 -102. [PubMed]
10. Kisenge PR, Howkins AT, Marvo V.P, Mchele JPD,SwaiNS,
Muller A, Houpt ER. Low CD4 count plus coma predicts Cryptococcal
Meningitis in Tanzania. BMC Infect Dis 2007; 7:39-43 doi:
10.1186/1471-2334-7-39. [PubMed]
11. Kumar S , Wanchu A, Chakrabarti A, Sharma A, Bambery P
et al . Cryptococcal meningitis in HIV infected experience from a north
Indian Tertiary care center. Neurol India 2008; 56(4): 444- 449. [PubMed]
12. Prasad KN, Agarwal J, Nag VL, Varma AK, Dixit AK,
Ayyagari A. Cryptococcal infection in patient with clinically diagnosed
meningitis in a tertiary care centre. Neurol India. 2003
Sep;51(3):364-6.
How to cite this article?
Shanthi B and Kannan I. A Case of Cryptococcal Meningitis in Hiv
positive patient in A tertiary care hospital in Kancheepurum district,
Tamilnadu, India. Int J Med Res Rev 2015;3(2):250-253. doi:
10.17511/ijmrr.2015.i2.044.